Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Nov;26(11):2651-2659.
doi: 10.3201/eid2611.181414.

Systematic Review and Meta-Analyses of Incidence for Group B Streptococcus Disease in Infants and Antimicrobial Resistance, China

Meta-Analysis

Systematic Review and Meta-Analyses of Incidence for Group B Streptococcus Disease in Infants and Antimicrobial Resistance, China

Yijun Ding et al. Emerg Infect Dis. 2020 Nov.

Abstract

We performed a systematic review and meta-analysis of the incidence, case-fatality rate (CFR), isolate antimicrobial resistance patterns, and serotype and sequence type distributions for invasive group B Streptococcus (GBS) disease in infants <1-89 days of age in China. We searched the PubMed/Medline, Embase, Wanfang, and China National Knowledge Infrastructure databases for research published during January 1, 2000-March 16, 2018, and identified 64 studies. Quality of included studies was assessed by using Cochrane tools. Incidence and CFR were estimated by using random-effects meta-analyses. Overall incidence was 0.55 (95% CI 0.35-0.74) cases/1,000 live births, and the CFR was 5% (95% CI 3%-6%). Incidence of GBS in young infants in China was higher than the estimated global incidence (0.49 cases/1,000 live births) and higher than previous estimates for Asia (0.3 cases/1,000 live births). Our findings suggest that implementation of additional GBS prevention efforts in China, including maternal vaccination, could be beneficial.

Keywords: China; GBS; antimicrobial resistance; bacteria; case-fatality rate; group B Streptococcus; group B Streptococcus disease; infants; meta-analyses; newborns; respiratory infections; streptococci; systematic review.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Process of study selection of systematic review and meta-analyses of incidence of group B Streptococcus disease in infants and antimicrobial resistance, China. CNKI, China National Knowledge Infrastructure.
Figure 2
Figure 2
Distribution of study locations in systematic review and meta-analyses of incidence of invasive group B Streptococcus disease, by province, China.
Figure 3
Figure 3
Overall incidence risk per 1,000 live births of invasive GBS disease in 13 infants <1–89 days of age, China. Vertical dashed line indicates a visual assessment of heterogeneity of the studies. If the vertical line can be drawn, forest plots indicate that all studies are similar enough to be included for meta-analysis. Error bars indicate 95% CIs. Reference details are provided in the Appendix. ES, effect size; GBS, group B Streptococcus disease.

References

    1. Heath PT, Balfour G, Weisner AM, Efstratiou A, Lamagni TL, Tighe H, et al. ; PHLS Group B Streptococcus Working Group. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet. 2004;363:292–4. 10.1016/S0140-6736(03)15389-5 - DOI - PubMed
    1. Sinha A, Russell LB, Tomczyk S, Verani JR, Schrag SJ, Berkley JA, et al. ; GBS Vaccine Cost-Effectiveness Analysis in Sub-Saharan Africa Working Group. Disease burden of group B Streptococcus among infants in sub-Saharan Africa: a systematic literature review and meta-analysis. Pediatr Infect Dis J. 2016;35:933–42. 10.1097/INF.0000000000001233 - DOI - PMC - PubMed
    1. Rivera L, Sáez-Llorens X, Feris-Iglesias J, Ip M, Saha S, Adrian PV, et al. Incidence and serotype distribution of invasive group B streptococcal disease in young infants: a multi-country observational study. BMC Pediatr. 2015;15:143. 10.1186/s12887-015-0460-2 - DOI - PMC - PubMed
    1. Madrid L, Seale AC, Kohli-Lynch M, Edmond KM, Lawn JE, Heath PT, et al. ; Infant GBS Disease Investigator Group. Infant group B streptococcal disease incidence and serotypes worldwide: systematic review and meta-analyses. Clin Infect Dis. 2017;65(suppl_2):S160–72. - PMC - PubMed
    1. Seale AC, Bianchi-Jassir F, Russell NJ, Kohli-Lynch M, Tann CJ, Hall J, et al. Estimates of the burden of group B streptococcal disease worldwide for pregnant women, stillbirths, and children. Clin Infect Dis. 2017;65(suppl_2):S200–19. - PMC - PubMed

Publication types

Substances